Physician profile
Mark G Carolan
NPI 1073516241
$3,222.64
in general payments reported to CMS, 2019-2025
19 companies · $795 in 2025
The $795 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $539 · 2021: $154 · 2022: $434 · 2023: $628 · 2024: $672 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,094.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $541.01 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $461.71 | 2022-2025 | Miebo, Vyzulta, Lotemax Sm |
| Amgen INC. | $279.67 | 2024-2025 | Tepezza |
| Dompe US, INC. | $271.63 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $262.82 | 2022-2024 | Cequa |
| Abbvie INC. | $155.88 | 2022-2025 | |
| Harrow Eye, LLC | $147.37 | 2024-2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $140.65 | 2021 | |
| Lkc Technologies, INC. | $132.24 | 2025 | |
| Oyster Point Pharma, INC. | $124.22 | 2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $123.35 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $121.36 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $96.19 | 2019 | |
| Optovue, INC. | $87.03 | 2019 | |
| New World Medical,INC. | $78.18 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $74.21 | 2021-2022 | |
| Alcon Vision LLC | $71.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.60 | 2022 | |
| Glaukos Corporation | $16.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Carolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.